China's biotech revival is pushing up prices of laboratory monkeys used in drug testing, as renewed R&D activity collides ...

Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, ...

Westchester County's life science industry has been growing for decades, thanks to the county's proximity to New York City, its assets in health care, access to a varied workforce and more. But future ...

The Harvard Life Lab, a new biotech research and enterprise facility in Allston, has selected 11 young companies to take up residence in advance of its November opening. The application to work in the ...

A Dutch life sciences firm plans to launch its first U.S. lab at Keene State College in December, and it envisions the Elm City as a base to cultivate biotech research in the region. Detact ...

Biotechnology usually is at the top of the list when discussions occur about economic drivers for the New Haven area and the state as a whole, both now and in the future. But there is a key impediment ...

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made several portfolio moves across biotech and growth stocks on Tuesday, December 30, 2025.

Few places have ridden the Covid biotech boom as successfully as Maryland. Baltimore boasts world-class institutions like the University of Maryland's medical school and Johns Hopkins University, but ...

Moorpark College is opening a new biotechnology analytical lab prior to the launch of the school's first bachelor's degree program, in applied biomanufacturing, next month. Elected officials have been ...

The future of lab-grown meat is coming. Or at least it feels that way, based on burgeoning interest in the biotech community. One by one, companies are staking out different animal tissues to grow in ...

Biotechnology stocks have slumped all year. Several vaunted experimental drugs--Provenge, Bexxar, ImClone's infamous Erbitux--have failed in clinical trials or FDA tests. BioWorld Financial Watch ...

Zai Lab has stopped development of a treatment for atopic dermatitis after it failed to beat placebo in a phase 2a trial. The Shanghai-based biotech licensed the candidate from GlaxoSmithKline in 2016 ...